Stealth BioTherapeutics Corp (MITO)

Currency in USD
0.3200
0.0000(0.00%)
Real-time Data·
Showing Stealth Bio historical data. For real-time data please try another search
Day's Range
0.32000.3300
52 wk Range
0.32000.3300
Key Statistics
Prev. Close
0.32
Open
0.3242
Day's Range
0.32-0.33
52 wk Range
0.32-0.33
Volume
-
Average Volume (3m)
208.47K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Stealth BioTherapeutics Corp Company Profile

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, engages in the development and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide which is in a phase 3 clinical trial to treat Barth syndrome, a phase 2/3 clinical trial for the treatment of Duchenne cardiomyopathy, a phase 2a clinical trial to treat Friedrich’s ataxia, a phase 2 clinical trial for treatment of dry age-related macular degeneration, phase 2 clinical trial to treat hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. Its product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson’s, Alzheimer’s, Huntington’s, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was formerly known as Stealth Peptides International, Inc. and changed its name to Stealth BioTherapeutics Corp in June 2015. The company was founded in 2006 and is based in Camana Bay, Cayman Islands.

Earnings

Latest Release
Mar 01, 2023
EPS / Forecast
-- / -0.01
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MITO Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.